Kaken Pharmaceutical Co.,Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Tokyo Japan (1948)

Organization Overview

First Clinical Trial
2001
NCT00514657
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Kaken | Kaken Pharmaceutical Co., Ltd